BROOKE VEER-SUNDERMEIER: Open Payments
NPI 1649757436 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 13 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $143 · 2025 $487
Food & beverage: $387Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $136 |
| Sumitomo Pharma America, Inc. | 1 | $103 |
| ABBVIE INC. | 3 | $63 |
| UROGEN PHARMA, INC. | 2 | $55 |
| TOLMAR, INC. | 1 | $53 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| 180 Medical, Inc. | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
Products named: ERLEADA, GEMTESA, BOTOX, JATENZO, PYLARIFY, CURE CATHETER, JOURNAVX.
Industry payments across OR — which companies pay providers there.
